Antiepileptic Medication During Pregnancy: Does Fetal Genotype Affect Outcome?
- 1 August 2007
- journal article
- review article
- Published by Springer Nature in Pediatric Research
- Vol. 62 (2) , 120-127
- https://doi.org/10.1203/pdr.0b013e3180a02e50
Abstract
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.Keywords
This publication has 78 references indexed in Scilit:
- In utero antiepileptic drug exposureNeurology, 2006
- Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromesArchives of Disease in Childhood: Fetal & Neonatal, 2006
- Maternal valproate dosage and foetal malformationsActa Neurologica Scandinavica, 2005
- EURAP: An International Registry of Antiepileptic Drugs and PregnancyEpilepsia, 2004
- Epilepsy and pregnancy: an obstetric perspectiveAmerican Journal of Obstetrics and Gynecology, 2004
- Experimental studies on reproductive toxicologic effects of lamotrigine in miceBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
- Epilepsy and pregnancy: lamotrigine as main drug usedActa Neurologica Scandinavica, 2003
- Pregnancy in the Woman with Epilepsy: Maternal and Fetal OutcomesSeminars in Neurology, 2002
- Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitutionJournal of Human Genetics, 2001
- The Teratogenicity of Anticonvulsant DrugsNew England Journal of Medicine, 2001